期刊文献+

外周原始神经外胚层肿瘤形态学 免疫表型及临床预后研究 被引量:21

A Morphological,Clinical Prognostic and Immunohistochemical Study in Primitive Neuroectodermal Tumor
暂未订购
导出
摘要 目的:探讨外周原始神经外胚层肿瘤(PNET)的临床表现,病理及免疫组织化学特点及预后。方法:对15例外周原始神经外胚层肿瘤进行临床资料及预后,病理组织形态学和超微结构特点及免疫组化表型研究。结果:患者以男性为主,男女之比约为6.5:1,年龄6~35岁,年龄中位数为16,发生部位较多,可发生在直肠,腹膜后,腹股沟,淋巴结,胸壁,睾丸,鼻腔及骨组织等;免疫组化:肿瘤均弥漫表达CD99,并不同程度地表达NSE,SYN,CgA等,但不表达CK,Desmin,LCA等,其中1例表达组织化学染色PAS,随访最长时间为24月。结论:PNET是一种发生在年轻男性,进展迅速,预后非常差的恶性小圆细胞肿瘤,认识其临床病理特点及免疫组化表型对于该恶性肿瘤的诊断及临床治疗意义重大。 Objective:To investigate the clinical,histomorphological and immunohistochemi-cal features in primitive neuroectodermal tumor (PNET).Methods:Fifteen cases of small round cell tumors are studied by histopathological,ultrastructural and immunohistochemical methods and clinical data.Results:There is prodominat male bias with male:female ratio of6.57:1,ages are ranged from6years to32years and median age is16years.The location of tumors are rectum,retroperitoneum,inguina,lymph node,chest wall,testis,nasal cavity and bone.Almost all tumor cells are strong and diffused staining for CD99,but weak or strong positive for NSE,Syn and CgA.All the tumor cells are negative for CK,Desmin and LCA.Only one case is positive for PAS histochemically.The follow-up period is about 4to24months.Conclusion:PNET is a kind of malignant small round cell tumors with rapid aggressive clinical course.The clinical and histopathological features are special and help for the diagnosis and treatment of PNET.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2003年第9期627-630,共4页 Chinese Journal of Clinical Oncology
关键词 原始神经外胚层肿瘤 免疫组化 组织形态学 临床特点 预后因素 Primitive neuroectodermal tumor(PNET)Morphology Immunohistochemistry Clinical data Prognostic factor
  • 相关文献

参考文献9

  • 1[1]Grirer HE. The Ewing family of tumors. Ewing's sarcoma and primitive nruroectodermal tumors [J]. Pediatr Clin North Am, 1997,44(4):991~1004
  • 2[2]Pauwels P, Ambros P, hattinger C, et al. Peripheral primitive neuroectodermal tumor of the cervix[J]. Mirchows Arch, 2000,436(1) :68~ 73
  • 3[3]Gu M, Antonescn CR, Guiter G, et al. Cytokeratin immunohistotivity in Ewing's sarcoma::prevalence in 50 cases confirmed by molecular diagnostic studies [J]. Am J Surg Pathol,2000,24(3) :400~416
  • 4[4]Granowetter L, West DC. The Ewing's sarcoma family of tumors: Ewing's sarcoma and peripheral primitive neuroectodermal tumor of bone and soft tissue[J]. Cancer Treat Res, 1997,92:253 ~308
  • 5[5]Charney DA, Charney JM, Ghali VS, et al. Primitive neuroectodermal tumor of the myocardium: a case report, review of the literature, immunohistochemical, and ultrastructural study[J].Hum Pathol, 1996, 27(12):1365~1369
  • 6[6]Ho DM, Hsu CY, Wong TF, et al. Atypical tetatoid/rhabdoid tumor of the central nervous system:a compatative study with primitive neuroectodermal tumor/medulloblastoma[J]. Acta Neuropathol (ber1), 2000,99(5):482~488
  • 7[7]Hill DA, Pfeifer JD, Dehner LP, et al. WT1 staining reliable differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study[J]. Am J Clin Pathol,2000,114(3) :345 ~ 353
  • 8[8]Jenkin RD, A1-Fawaz I, A1-Shabanah M, et al. Localised Ewing sarcom/PNET of bone-prognostic factor and international data comparison[J]. Med Pediatr Oncol, 2002, 39(6):586~593
  • 9[9]Baldini EH, Demetri GD, Fletcher CD, et al. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous diseaes on outcome [J].Ann Surg, 1999, 230(1):79~86

同被引文献137

引证文献21

二级引证文献48

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部